Nautilus Historical Cash Flow

NAUT Stock  USD 2.11  0.06  2.76%   
Analysis of Nautilus Biotechnology cash flow over time is an excellent tool to project Nautilus Biotechnology future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Total Cash From Financing Activities of 349.6 K or End Period Cash Flow of 19.4 M as it is a great indicator of Nautilus Biotechnology ability to facilitate future growth, repay debt on time or pay out dividends.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Nautilus Biotechnology latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Nautilus Biotechnology is a good buy for the upcoming year.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nautilus Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
For more information on how to buy Nautilus Stock please use our How to Invest in Nautilus Biotechnology guide.

About Nautilus Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Nautilus balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Nautilus's non-liquid assets can be easily converted into cash.

Nautilus Biotechnology Cash Flow Chart

Change To Netincome is likely to gain to about 12.5 M in 2024, whereas Sale Purchase Of Stock is likely to drop slightly above 250.8 K in 2024.

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Total Cashflows From Investing Activities

The net amount of cash used in or generated from a company's investment activities, such as purchasing or selling assets, during a reporting period.
Most accounts from Nautilus Biotechnology's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Nautilus Biotechnology current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nautilus Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
For more information on how to buy Nautilus Stock please use our How to Invest in Nautilus Biotechnology guide.Change To Netincome is likely to gain to about 12.5 M in 2024, whereas Sale Purchase Of Stock is likely to drop slightly above 250.8 K in 2024.

Nautilus Biotechnology cash flow statement Correlations

0.10.38-0.280.32-0.30.03-0.01-0.14-0.410.14-0.69-0.12-0.090.170.11-0.11
0.1-0.410.21-0.350.320.21-0.190.09-0.170.1-0.190.080.2-0.110.01-0.01
0.38-0.41-0.840.99-0.990.56-0.650.64-0.820.72-0.270.660.26-0.66-0.530.53
-0.280.21-0.84-0.870.88-0.270.62-0.750.83-0.88-0.06-0.830.050.750.8-0.82
0.32-0.350.99-0.87-1.00.59-0.70.72-0.860.78-0.20.740.26-0.74-0.610.61
-0.30.32-0.990.88-1.0-0.60.72-0.750.88-0.80.18-0.77-0.260.770.64-0.64
0.030.210.56-0.270.59-0.6-0.790.63-0.680.5-0.40.560.79-0.69-0.260.23
-0.01-0.19-0.650.62-0.70.72-0.79-0.760.82-0.740.31-0.78-0.720.840.44-0.45
-0.140.090.64-0.750.72-0.750.63-0.76-0.80.940.210.960.24-0.97-0.860.85
-0.41-0.17-0.820.83-0.860.88-0.680.82-0.8-0.890.3-0.83-0.330.820.66-0.66
0.140.10.72-0.880.78-0.80.5-0.740.94-0.890.060.910.13-0.88-0.830.84
-0.69-0.19-0.27-0.06-0.20.18-0.40.310.210.30.060.24-0.6-0.16-0.520.51
-0.120.080.66-0.830.74-0.770.56-0.780.96-0.830.910.240.19-0.98-0.90.91
-0.090.20.260.050.26-0.260.79-0.720.24-0.330.13-0.60.19-0.350.24-0.24
0.17-0.11-0.660.75-0.740.77-0.690.84-0.970.82-0.88-0.16-0.98-0.350.83-0.83
0.110.01-0.530.8-0.610.64-0.260.44-0.860.66-0.83-0.52-0.90.240.83-1.0
-0.11-0.010.53-0.820.61-0.640.23-0.450.85-0.660.840.510.91-0.24-0.83-1.0
Click cells to compare fundamentals

Nautilus Biotechnology Account Relationship Matchups

Nautilus Biotechnology cash flow statement Accounts

201920202021202220232024 (projected)
Sale Purchase Of Stock(874.3K)154.5M(8.0M)232K264K250.8K
Change In Cash(1.2B)36.6M149.2M(71.0M)(95.1M)(99.8M)
Free Cash Flow(10.6M)(14.9M)(41.5M)(48.1M)(54.2M)(56.9M)
Change In Working Capital(545K)(1.4M)(22K)(788K)(3.2M)(3.1M)
Other Cashflows From Financing Activities36K75.9M327.4M562K368K349.6K
Other Non Cash Items(157K)295K320K(890K)(2.7M)(2.8M)
Capital Expenditures926K921K2.3M2.3M2.4M1.6M
Total Cash From Operating Activities(9.7M)(14.0M)(39.2M)(45.8M)(51.7M)(54.3M)
Net Income(9.6M)(15.6M)(50.3M)(57.9M)(63.7M)(60.5M)
Total Cash From Financing Activities36K75.9M327.4M562K368K349.6K
End Period Cash Flow595K37.2M186.5M115.5M20.4M19.4M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Nautilus Stock Analysis

When running Nautilus Biotechnology's price analysis, check to measure Nautilus Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nautilus Biotechnology is operating at the current time. Most of Nautilus Biotechnology's value examination focuses on studying past and present price action to predict the probability of Nautilus Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nautilus Biotechnology's price. Additionally, you may evaluate how the addition of Nautilus Biotechnology to your portfolios can decrease your overall portfolio volatility.